Table of Content

1 Solid Tumor Drug Market Overview
1.1 Solid Tumor Drug Product Scope
1.2 Solid Tumor Drug Segment by Type
1.2.1 Global Solid Tumor Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Solid Tumor Drug Segment by Application
1.3.1 Global Solid Tumor Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Radiology
1.3.5 Others
1.4 Solid Tumor Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Solid Tumor Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Solid Tumor Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Solid Tumor Drug Price Trends (2016-2027)

2 Solid Tumor Drug Estimates and Forecasts by Region
2.1 Global Solid Tumor Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Solid Tumor Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Solid Tumor Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Solid Tumor Drug Revenue Market Share by Region (2016-2021)
2.3 Global Solid Tumor Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Solid Tumor Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Solid Tumor Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Solid Tumor Drug Estimates and Projections (2016-2027)
2.4.2 Europe Solid Tumor Drug Estimates and Projections (2016-2027)
2.4.3 China Solid Tumor Drug Estimates and Projections (2016-2027)
2.4.4 Japan Solid Tumor Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Solid Tumor Drug Estimates and Projections (2016-2027)
2.4.6 India Solid Tumor Drug Estimates and Projections (2016-2027)

3 Global Solid Tumor Drug Competition Landscape by Players
3.1 Global Top Solid Tumor Drug Players by Sales (2016-2021)
3.2 Global Top Solid Tumor Drug Players by Revenue (2016-2021)
3.3 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2020)
3.4 Global Solid Tumor Drug Average Price by Company (2016-2021)
3.5 Manufacturers Solid Tumor Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Solid Tumor Drug Market Size by Type
4.1 Global Solid Tumor Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Solid Tumor Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Solid Tumor Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Solid Tumor Drug Price by Type (2016-2021)
4.2 Global Solid Tumor Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Solid Tumor Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Solid Tumor Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Solid Tumor Drug Price Forecast by Type (2022-2027)

5 Global Solid Tumor Drug Market Size by Application
5.1 Global Solid Tumor Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Solid Tumor Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Solid Tumor Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Solid Tumor Drug Price by Application (2016-2021)
5.2 Global Solid Tumor Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Solid Tumor Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Solid Tumor Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Solid Tumor Drug Price Forecast by Application (2022-2027)

6 North America Solid Tumor Drug Market Facts & Figures
6.1 North America Solid Tumor Drug Sales by Company
6.1.1 North America Solid Tumor Drug Sales by Company (2016-2021)
6.1.2 North America Solid Tumor Drug Revenue by Company (2016-2021)
6.2 North America Solid Tumor Drug Sales Breakdown by Type
6.2.1 North America Solid Tumor Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Solid Tumor Drug Sales Breakdown by Type (2022-2027)
6.3 North America Solid Tumor Drug Sales Breakdown by Application
6.3.1 North America Solid Tumor Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Solid Tumor Drug Sales Breakdown by Application (2022-2027)

7 Europe Solid Tumor Drug Market Facts & Figures
7.1 Europe Solid Tumor Drug Sales by Company
7.1.1 Europe Solid Tumor Drug Sales by Company (2016-2021)
7.1.2 Europe Solid Tumor Drug Revenue by Company (2016-2021)
7.2 Europe Solid Tumor Drug Sales Breakdown by Type
7.2.1 Europe Solid Tumor Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Solid Tumor Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Solid Tumor Drug Sales Breakdown by Application
7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)

8 China Solid Tumor Drug Market Facts & Figures
8.1 China Solid Tumor Drug Sales by Company
8.1.1 China Solid Tumor Drug Sales by Company (2016-2021)
8.1.2 China Solid Tumor Drug Revenue by Company (2016-2021)
8.2 China Solid Tumor Drug Sales Breakdown by Type
8.2.1 China Solid Tumor Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Solid Tumor Drug Sales Breakdown by Type (2022-2027)
8.3 China Solid Tumor Drug Sales Breakdown by Application
8.3.1 China 152 Sales Breakdown by Application (2016-2021)
8.3.2 China 152 Sales Breakdown by Application (2022-2027)

9 Japan Solid Tumor Drug Market Facts & Figures
9.1 Japan Solid Tumor Drug Sales by Company
9.1.1 Japan Solid Tumor Drug Sales by Company (2016-2021)
9.1.2 Japan Solid Tumor Drug Revenue by Company (2016-2021)
9.2 Japan Solid Tumor Drug Sales Breakdown by Type
9.2.1 Japan Solid Tumor Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Solid Tumor Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Solid Tumor Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Solid Tumor Drug Market Facts & Figures
10.1 Southeast Asia Solid Tumor Drug Sales by Company
10.1.1 Southeast Asia Solid Tumor Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Solid Tumor Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Solid Tumor Drug Sales Breakdown by Type
10.2.1 Southeast Asia Solid Tumor Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Solid Tumor Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Solid Tumor Drug Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Solid Tumor Drug Market Facts & Figures
11.1 India Solid Tumor Drug Sales by Company
11.1.1 India Solid Tumor Drug Sales by Company (2016-2021)
11.1.2 India Solid Tumor Drug Revenue by Company (2016-2021)
11.2 India Solid Tumor Drug Sales Breakdown by Type
11.2.1 India Solid Tumor Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Solid Tumor Drug Sales Breakdown by Type (2022-2027)
11.3 India Solid Tumor Drug Sales Breakdown by Application
11.3.1 India Solid Tumor Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Solid Tumor Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Solid Tumor Drug Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Solid Tumor Drug Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Biogen
12.2.1 Biogen Corporation Information
12.2.2 Biogen Business Overview
12.2.3 Biogen Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biogen Solid Tumor Drug Products Offered
12.2.5 Biogen Recent Development
12.3 Baxter
12.3.1 Baxter Corporation Information
12.3.2 Baxter Business Overview
12.3.3 Baxter Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Baxter Solid Tumor Drug Products Offered
12.3.5 Baxter Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Corporation Information
12.4.2 Celgene Corporation Business Overview
12.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Celgene Corporation Solid Tumor Drug Products Offered
12.4.5 Celgene Corporation Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Corporation Information
12.5.2 Abbott Laboratories Business Overview
12.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abbott Laboratories Solid Tumor Drug Products Offered
12.5.5 Abbott Laboratories Recent Development
12.6 Pfizer Inc
12.6.1 Pfizer Inc Corporation Information
12.6.2 Pfizer Inc Business Overview
12.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Inc Solid Tumor Drug Products Offered
12.6.5 Pfizer Inc Recent Development
12.7 Amgen Limited & Amgen Ireland Limited
12.7.1 Amgen Limited & Amgen Ireland Limited Corporation Information
12.7.2 Amgen Limited & Amgen Ireland Limited Business Overview
12.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Products Offered
12.7.5 Amgen Limited & Amgen Ireland Limited Recent Development
12.8 Bristol-Myers Squibb Company
12.8.1 Bristol-Myers Squibb Company Corporation Information
12.8.2 Bristol-Myers Squibb Company Business Overview
12.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bristol-Myers Squibb Company Solid Tumor Drug Products Offered
12.8.5 Bristol-Myers Squibb Company Recent Development
12.9 GlaxoSmithKline plc.
12.9.1 GlaxoSmithKline plc. Corporation Information
12.9.2 GlaxoSmithKline plc. Business Overview
12.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GlaxoSmithKline plc. Solid Tumor Drug Products Offered
12.9.5 GlaxoSmithKline plc. Recent Development
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.10.2 F. Hoffmann-La Roche Ltd. Business Overview
12.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Products Offered
12.10.5 F. Hoffmann-La Roche Ltd. Recent Development
12.11 Eli Lilly and Company
12.11.1 Eli Lilly and Company Corporation Information
12.11.2 Eli Lilly and Company Business Overview
12.11.3 Eli Lilly and Company Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Eli Lilly and Company Solid Tumor Drug Products Offered
12.11.5 Eli Lilly and Company Recent Development
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Corporation Information
12.12.2 Johnson & Johnson Business Overview
12.12.3 Johnson & Johnson Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Johnson & Johnson Solid Tumor Drug Products Offered
12.12.5 Johnson & Johnson Recent Development

13 Solid Tumor Drug Manufacturing Cost Analysis
13.1 Solid Tumor Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Solid Tumor Drug
13.4 Solid Tumor Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Solid Tumor Drug Distributors List
14.3 Solid Tumor Drug Customers

15 Market Dynamics
15.1 Solid Tumor Drug Market Trends
15.2 Solid Tumor Drug Drivers
15.3 Solid Tumor Drug Market Challenges
15.4 Solid Tumor Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Solid Tumor Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Solid Tumor Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Solid Tumor Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Solid Tumor Drug Sales (K MT) by Region (2016-2021)
Table 5. Global Solid Tumor Drug Sales Market Share by Region (2016-2021)
Table 6. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Solid Tumor Drug Revenue Share by Region (2016-2021)
Table 8. Global Solid Tumor Drug Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Solid Tumor Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Solid Tumor Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Solid Tumor Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Solid Tumor Drug Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Solid Tumor Drug Sales Share by Company (2016-2021)
Table 14. Global Solid Tumor Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Solid Tumor Drug Revenue Share by Company (2016-2021)
Table 16. Global Solid Tumor Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Drug as of 2020)
Table 17. Global Solid Tumor Drug Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Solid Tumor Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Solid Tumor Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Solid Tumor Drug Sales (K MT) by Type (2016-2021)
Table 22. Global Solid Tumor Drug Sales Share by Type (2016-2021)
Table 23. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Solid Tumor Drug Price (USD/MT) by Type (2016-2021)
Table 25. Global Solid Tumor Drug Sales Share by Type (2022-2027)
Table 26. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Solid Tumor Drug Revenue Share by Type (2022-2027)
Table 28. Global Solid Tumor Drug Price (USD/MT) by Type (2022-2027)
Table 29. Global Solid Tumor Drug Sales (K MT) by Application (2016-2021)
Table 30. Global Solid Tumor Drug Sales Share by Application (2016-2021)
Table 31. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Solid Tumor Drug Price (USD/MT) by Application (2016-2021)
Table 33. Global Solid Tumor Drug Sales (K MT) by Application (2022-2027)
Table 34. Global Solid Tumor Drug Sales Share by Application (2022-2027)
Table 35. Global Solid Tumor Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Solid Tumor Drug Revenue Share by Application (2022-2027)
Table 37. Global Solid Tumor Drug Price (USD/MT) by Application (2022-2027)
Table 38. North America Solid Tumor Drug Sales (K MT) by Company (2016-2021)
Table 39. North America Solid Tumor Drug Sales Market Share by Company (2016-2021)
Table 40. North America Solid Tumor Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Solid Tumor Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Solid Tumor Drug Sales by Type (2016-2021) & (K MT)
Table 43. North America Solid Tumor Drug Sales Market Share by Type (2016-2021)
Table 44. North America Solid Tumor Drug Sales by Type (2022-2027) & (K MT)
Table 45. North America Solid Tumor Drug Sales Market Share by Type (2022-2027)
Table 46. North America Solid Tumor Drug Sales by Application (2016-2021) & (K MT)
Table 47. North America Solid Tumor Drug Sales Market Share by Application (2016-2021)
Table 48. North America Solid Tumor Drug Sales by Application (2022-2027) & (K MT)
Table 49. North America Solid Tumor Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Solid Tumor Drug Sales (K MT) by Company (2016-2021)
Table 51. Europe Solid Tumor Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Solid Tumor Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Solid Tumor Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Solid Tumor Drug Sales by Type (2016-2021) & (K MT)
Table 55. Europe Solid Tumor Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Solid Tumor Drug Sales by Type (2022-2027) & (K MT)
Table 57. Europe Solid Tumor Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Solid Tumor Drug Sales by Application (2016-2021) & (K MT)
Table 59. Europe Solid Tumor Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Solid Tumor Drug Sales by Application (2022-2027) & (K MT)
Table 61. Europe Solid Tumor Drug Sales Market Share by Application (2022-2027)
Table 62. China Solid Tumor Drug Sales (K MT) by Company (2016-2021)
Table 63. China Solid Tumor Drug Sales Market Share by Company (2016-2021)
Table 64. China Solid Tumor Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Solid Tumor Drug Revenue Market Share by Company (2016-2021)
Table 66. China Solid Tumor Drug Sales by Type (2016-2021) & (K MT)
Table 67. China Solid Tumor Drug Sales Market Share by Type (2016-2021)
Table 68. China Solid Tumor Drug Sales by Type (2022-2027) & (K MT)
Table 69. China Solid Tumor Drug Sales Market Share by Type (2022-2027)
Table 70. China Solid Tumor Drug Sales by Application (2016-2021) & (K MT)
Table 71. China Solid Tumor Drug Sales Market Share by Application (2016-2021)
Table 72. China Solid Tumor Drug Sales by Application (2022-2027) & (K MT)
Table 73. China Solid Tumor Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Solid Tumor Drug Sales (K MT) by Company (2016-2021)
Table 75. Japan Solid Tumor Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Solid Tumor Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Solid Tumor Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Solid Tumor Drug Sales by Type (2016-2021) & (K MT)
Table 79. Japan Solid Tumor Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Solid Tumor Drug Sales by Type (2022-2027) & (K MT)
Table 81. Japan Solid Tumor Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Solid Tumor Drug Sales by Application (2016-2021) & (K MT)
Table 83. Japan Solid Tumor Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Solid Tumor Drug Sales by Application (2022-2027) & (K MT)
Table 85. Japan Solid Tumor Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Solid Tumor Drug Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Solid Tumor Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Solid Tumor Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Solid Tumor Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Solid Tumor Drug Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Solid Tumor Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Solid Tumor Drug Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Solid Tumor Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Solid Tumor Drug Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Solid Tumor Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Solid Tumor Drug Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Solid Tumor Drug Sales Market Share by Application (2022-2027)
Table 98. India Solid Tumor Drug Sales (K MT) by Company (2016-2021)
Table 99. India Solid Tumor Drug Sales Market Share by Company (2016-2021)
Table 100. India Solid Tumor Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Solid Tumor Drug Revenue Market Share by Company (2016-2021)
Table 102. India Solid Tumor Drug Sales by Type (2016-2021) & (K MT)
Table 103. India Solid Tumor Drug Sales Market Share by Type (2016-2021)
Table 104. India Solid Tumor Drug Sales by Type (2022-2027) & (K MT)
Table 105. India Solid Tumor Drug Sales Market Share by Type (2022-2027)
Table 106. India Solid Tumor Drug Sales by Application (2016-2021) & (K MT)
Table 107. India Solid Tumor Drug Sales Market Share by Application (2016-2021)
Table 108. India Solid Tumor Drug Sales by Application (2022-2027) & (K MT)
Table 109. India Solid Tumor Drug Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. AstraZeneca Solid Tumor Drug Product
Table 114. AstraZeneca Recent Development
Table 115. Biogen Corporation Information
Table 116. Biogen Description and Business Overview
Table 117. Biogen Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Biogen Solid Tumor Drug Product
Table 119. Biogen Recent Development
Table 120. Baxter Corporation Information
Table 121. Baxter Description and Business Overview
Table 122. Baxter Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Baxter Solid Tumor Drug Product
Table 124. Baxter Recent Development
Table 125. Celgene Corporation Corporation Information
Table 126. Celgene Corporation Description and Business Overview
Table 127. Celgene Corporation Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Celgene Corporation Solid Tumor Drug Product
Table 129. Celgene Corporation Recent Development
Table 130. Abbott Laboratories Corporation Information
Table 131. Abbott Laboratories Description and Business Overview
Table 132. Abbott Laboratories Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Abbott Laboratories Solid Tumor Drug Product
Table 134. Abbott Laboratories Recent Development
Table 135. Pfizer Inc Corporation Information
Table 136. Pfizer Inc Description and Business Overview
Table 137. Pfizer Inc Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Pfizer Inc Solid Tumor Drug Product
Table 139. Pfizer Inc Recent Development
Table 140. Amgen Limited & Amgen Ireland Limited Corporation Information
Table 141. Amgen Limited & Amgen Ireland Limited Description and Business Overview
Table 142. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product
Table 144. Amgen Limited & Amgen Ireland Limited Recent Development
Table 145. Bristol-Myers Squibb Company Corporation Information
Table 146. Bristol-Myers Squibb Company Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Bristol-Myers Squibb Company Description and Business Overview
Table 148. Bristol-Myers Squibb Company Solid Tumor Drug Product
Table 149. Bristol-Myers Squibb Company Recent Development
Table 150. GlaxoSmithKline plc. Corporation Information
Table 151. GlaxoSmithKline plc. Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. GlaxoSmithKline plc. Description and Business Overview
Table 153. GlaxoSmithKline plc. Solid Tumor Drug Product
Table 154. GlaxoSmithKline plc. Recent Development
Table 155. F. Hoffmann-La Roche Ltd. Corporation Information
Table 156. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 157. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product
Table 159. F. Hoffmann-La Roche Ltd. Recent Development
Table 160. Eli Lilly and Company Corporation Information
Table 161. Eli Lilly and Company Description and Business Overview
Table 162. Eli Lilly and Company Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Eli Lilly and Company Solid Tumor Drug Product
Table 164. Eli Lilly and Company Recent Development
Table 165. Johnson & Johnson Corporation Information
Table 166. Johnson & Johnson Description and Business Overview
Table 167. Johnson & Johnson Solid Tumor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Johnson & Johnson Solid Tumor Drug Product
Table 169. Johnson & Johnson Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Solid Tumor Drug Distributors List
Table 173. Solid Tumor Drug Customers List
Table 174. Solid Tumor Drug Market Trends
Table 175. Solid Tumor Drug Market Drivers
Table 176. Solid Tumor Drug Market Challenges
Table 177. Solid Tumor Drug Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Solid Tumor Drug Product Picture
Figure 2. Global Solid Tumor Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Small Molecules Product Picture
Figure 4. Biologics Product Picture
Figure 5. Global Solid Tumor Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Neurology Examples
Figure 8. Radiology Examples
Figure 9. Others Examples
Figure 10. Global Solid Tumor Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Solid Tumor Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Solid Tumor Drug Sales (K MT) Growth Rate (2016-2027)
Figure 13. Global Solid Tumor Drug Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Solid Tumor Drug Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Solid Tumor Drug Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Solid Tumor Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Solid Tumor Drug Sales (K MT) Growth Rate (2016-2027)
Figure 18. Europe Solid Tumor Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Solid Tumor Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Solid Tumor Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Solid Tumor Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Solid Tumor Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Solid Tumor Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Solid Tumor Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Solid Tumor Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Solid Tumor Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Solid Tumor Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Solid Tumor Drug Players Market Share by Revenue in Solid Tumor Drug: 2016 & 2020
Figure 29. Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Solid Tumor Drug Revenue Share by Type (2016-2021)
Figure 31. Global Solid Tumor Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Solid Tumor Drug Revenue Share by Application (2016-2021)
Figure 33. Global Solid Tumor Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Solid Tumor Drug Sales Market Share by Type in 2020
Figure 35. North America Solid Tumor Drug Sales Market Share by Application in 2020
Figure 36. Europe Solid Tumor Drug Sales Market Share by Type in 2020
Figure 37. Europe Solid Tumor Drug Sales Market Share by Application in 2020
Figure 38. China Solid Tumor Drug Sales Market Share by Type in 2020
Figure 39. China Solid Tumor Drug Sales Market Share by Application in 2020
Figure 40. Japan Solid Tumor Drug Sales Market Share by Type in 2020
Figure 41. Japan Solid Tumor Drug Sales Market Share by Application in 2020
Figure 42. Southeast Asia Solid Tumor Drug Sales Market Share by Type in 2020
Figure 43. Southeast Asia Solid Tumor Drug Sales Market Share by Application in 2020
Figure 44. India Solid Tumor Drug Sales Market Share by Type in 2020
Figure 45. India Solid Tumor Drug Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Solid Tumor Drug
Figure 48. Manufacturing Process Analysis of Solid Tumor Drug
Figure 49. Solid Tumor Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed